JPS63221246A - Dry type immunoassary element - Google Patents
Dry type immunoassary elementInfo
- Publication number
- JPS63221246A JPS63221246A JP5463587A JP5463587A JPS63221246A JP S63221246 A JPS63221246 A JP S63221246A JP 5463587 A JP5463587 A JP 5463587A JP 5463587 A JP5463587 A JP 5463587A JP S63221246 A JPS63221246 A JP S63221246A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- antigen
- reagent
- porous layer
- reagent layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 55
- 239000000427 antigen Substances 0.000 claims abstract description 48
- 102000036639 antigens Human genes 0.000 claims abstract description 48
- 108091007433 antigens Proteins 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims description 16
- 238000003892 spreading Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 238000003018 immunoassay Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 20
- 102000004190 Enzymes Human genes 0.000 abstract description 20
- 238000001514 detection method Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 238000004458 analytical method Methods 0.000 abstract description 7
- 238000002372 labelling Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 132
- 229940088598 enzyme Drugs 0.000 description 18
- 238000011161 development Methods 0.000 description 10
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 10
- 108010010803 Gelatin Proteins 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 229920001477 hydrophilic polymer Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229940034208 thyroxine Drugs 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- -1 amine pyridinium salts Chemical class 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 3
- 239000002759 woven fabric Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000011146 organic particle Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- UTXPWBKKZFLMPZ-UHFFFAOYSA-N 2-aminoacridine Chemical compound C1=CC=CC2=CC3=CC(N)=CC=C3N=C21 UTXPWBKKZFLMPZ-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- KLYWOECPXNAJPC-UHFFFAOYSA-N naphthalen-1-amine;naphthalen-2-amine Chemical compound C1=CC=CC2=CC(N)=CC=C21.C1=CC=C2C(N)=CC=CC2=C1 KLYWOECPXNAJPC-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229910000349 titanium oxysulfate Inorganic materials 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical class C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
【発明の詳細な説明】
[発明の分野]
本発明は抗原/抗体反応を利用する免疫学的分析に有用
な分析要素に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of the Invention] The present invention relates to analytical elements useful for immunological analysis utilizing antigen/antibody reactions.
[従来技術]
乾式分析要素を用いて体液などに含有されている生化学
物質を定量する分析方法が知られている(例えば特開昭
49−53888号、同55−164356号、同59
−102388号)、乾式分析要素では一般に、被検成
分と分析要素内に含まれる試薬との反応の反応生成物ま
たは未反応成分の量を、光学的に、例えば発色、変色、
蛍光、発光等の分光測光により測定し、被検成分を定量
する。乾式分析要素を用いると、簡便、迅速に、しかも
高い精度で液体中の特定成分、例えば生化学的活性物質
の分析ができる。[Prior Art] Analytical methods for quantifying biochemical substances contained in body fluids using dry analytical elements are known (for example, Japanese Patent Application Laid-open Nos. 49-53888, 55-164356, and 59).
-102388), dry analytical elements generally measure the amount of reaction products or unreacted components of the reaction between the test component and the reagent contained within the analytical element by optical means, such as color development, discoloration,
Measure by spectrophotometry such as fluorescence and luminescence to quantify the test component. By using a dry analytical element, it is possible to analyze a specific component, such as a biochemically active substance, in a liquid simply, quickly, and with high precision.
乾式分析要素を利用した免疫学的分析も、例えば特開昭
49−53888号、特開昭59−102388号、米
国特許4,459.358号等の記載により知られてい
る。Immunological analysis using dry analytical elements is also known, for example, as described in JP-A-49-53888, JP-A-59-102388, and US Pat. No. 4,459.358.
免疫学における抗原抗体反応は互いに対応する抗原また
は抗体のみに特異的に反応し結合する反応であり、自己
免疫疾患の診断、生体内微量物質の検出などに広く利用
されている。しかし操作に熟練を要するため、臨床検査
のためには簡便な操作で精度良く測定できる方法が望ま
れている。Antigen-antibody reactions in immunology are reactions that specifically react and bind only mutually corresponding antigens or antibodies, and are widely used for diagnosis of autoimmune diseases, detection of trace substances in living organisms, etc. However, since it requires skill to operate, a method that can perform accurate measurements with simple operations is desired for clinical testing.
多層分析要素を利用した簡便な抗原量測定法の一つの典
型は特開昭59−77356号に開示されたものである
。この方法で用いている分析要素は、蛍光標識抗原を含
む展開層と、多孔性媒体から成る分配層と、固定化抗体
を含む反応層を積層したもので、被検液中の抗原と標識
抗原との間での競争的な抗原抗体反応を利用し、抗原の
量が蛍光強度の減少として測定される。One typical method of simple antigen amount measurement using a multilayer analytical element is disclosed in Japanese Patent Application Laid-Open No. 77356/1983. The analytical element used in this method is a stack of a development layer containing a fluorescently labeled antigen, a distribution layer made of a porous medium, and a reaction layer containing an immobilized antibody. The amount of antigen is measured as a decrease in fluorescence intensity using a competitive antigen-antibody reaction.
また検出感度の比較的高い免疫分析法として、酵素免疫
分析(EIA)が考えられている。典型的な方法は特公
昭53−27763号によって知られ、酵素を抗原また
はその誘導体に結合させて、酵素標識抗原をつくり、酵
素活性に対する抗原の効果の測定により、被検液中の抗
原を分析する方法である。この方法では、抗体と結合し
た酵素標識抗原(Bで示される)と未結合の酵素標識抗
原(Fで示される)とを分離する(いわゆるB/F分M
)か、BとFとで活性が変化する酵素系が必要とされる
。Enzyme immunoassay (EIA) is also considered as an immunoassay method with relatively high detection sensitivity. A typical method is known from Japanese Patent Publication No. 53-27763, in which an enzyme is bound to an antigen or its derivative to create an enzyme-labeled antigen, and the antigen in a test solution is analyzed by measuring the effect of the antigen on enzyme activity. This is the way to do it. In this method, the enzyme-labeled antigen bound to the antibody (denoted by B) and the unbound enzyme-labeled antigen (denoted by F) are separated (the so-called B/F fraction M
), or an enzyme system whose activity changes between B and F is required.
これらの系を成立させるためには、抗体と標識抗原、ま
たは抗体標識物と抗原誘導体の、いずれかの二成分が必
須であり、検体との接触前にはこれらの二成分が互いに
反応しないようにしておかないと、検出感度(信号/背
景比)が著しく低下する。これまで知られた乾式分析要
素の多くは、この要因のために、満足すべき分析感度を
得ることができなかった。In order to establish these systems, two components are essential: an antibody and a labeled antigen, or an antibody label and an antigen derivative, and care must be taken to ensure that these two components do not react with each other before contact with the sample. If this is not done, the detection sensitivity (signal/background ratio) will drop significantly. Many of the dry analytical elements known so far have not been able to obtain satisfactory analytical sensitivity due to this factor.
[発明の目的]
本発明の目的は、高い分析感度と定量分析精度を有する
、乾式免疫学的分析要素およびその製造方法の提供にあ
る。[Object of the Invention] An object of the present invention is to provide a dry immunological analytical element and a method for producing the same, which have high analytical sensitivity and quantitative analytical accuracy.
[発明の構成コ
本発明の上記目的の第一は、一体化された少なくとも2
つの水浸透性層から成り、該層の一つは多孔性層、他の
一つは試薬層であり、試薬層は多孔性層の液体を受容す
る面と反対側に位置しており、抗原/抗体反応に関与す
る成分を水浸透性層に含む酵素活性測定用乾式分析要素
であって、上記抗原/抗体反応に関与する成分の一つは
標識抗原、他の一つは非標識および標識抗原に対する抗
体であり、被検液が接触するまで、前記抗体の実質的に
全部が多孔性層に含まれ、前記標識抗原の実質的に全部
が試薬層に含まれることを特徴とする乾式分析要素によ
って達成された。[Configuration of the Invention] The first object of the present invention is to provide an integrated at least two
It consists of two water-permeable layers, one of which is a porous layer and the other is a reagent layer, the reagent layer being located on the opposite side of the porous layer to the liquid-receiving surface, and the antigen /A dry analytical element for enzyme activity measurement containing components involved in antibody reaction in a water-permeable layer, one of the components involved in the antigen/antibody reaction being a labeled antigen and the other being unlabeled and labeled. A dry analysis characterized in that the antibody is an antibody against an antigen, and substantially all of the antibody is contained in a porous layer and substantially all of the labeled antigen is contained in a reagent layer until it comes into contact with a test liquid. Achieved by elements.
上記目的の第二は、一体化された少なくとも2つの水浸
透性層から成り、水浸透性の多孔性層と試薬層を少なく
とも有し、試薬層は該多孔性層の液体を受容する面と反
対側に位置しており、抗原/抗体反応に関与する成分を
水浸透性層に含む酵素活性測定用乾式分析要素を製造す
るに際し、前記標識抗原を含む試薬層の上に多孔性層を
設けた後、前記抗体を含み試薬層中の標識抗原を溶解ま
たは可溶化しない組成物を該多孔性層に塗布または含浸
することによって達成された。The second of the above objects comprises at least two water-permeable layers integrated, having at least a water-permeable porous layer and a reagent layer, the reagent layer being a liquid-receiving surface of the porous layer. When producing a dry analytical element for measuring enzyme activity, which contains components involved in antigen/antibody reactions in the water-permeable layer, which is located on the opposite side, a porous layer is provided on the reagent layer containing the labeled antigen. This was achieved by coating or impregnating the porous layer with a composition that contains the antibody and does not dissolve or solubilize the labeled antigen in the reagent layer.
上記目的の第二はまた、上記分析要素を製造するに際し
、前記標識抗原を含む試薬層の上に、前記抗体を含む組
成物を予め塗布または含浸した多孔性層を設けることに
より、達成された。The second objective was also achieved by providing a porous layer pre-coated or impregnated with the composition containing the antibody on the reagent layer containing the labeled antigen when manufacturing the analytical element. .
特に、標識抗原を含み親水性高分子を結合剤とする試薬
層を塗布等により設け、その上に多孔性層を設けた後、
前記抗体を含み試薬層の親水性高分子を膨潤させない組
成物を多孔性層に塗布または含浸する方法は、有用な方
法の一つである。試薬層の親水性高分子を膨潤さすない
組成物としては、例えばアルコール類、エーテル類、ケ
トン類のような有機溶媒の溶液が有用である0例えばエ
タノール、メタノール、アセトン、エチルセロソルブ等
が利用できる。In particular, after providing a reagent layer containing a labeled antigen and using a hydrophilic polymer as a binder by coating, etc., and providing a porous layer thereon,
One useful method is to apply or impregnate the porous layer with a composition that contains the antibody and does not swell the hydrophilic polymer in the reagent layer. As a composition that does not swell the hydrophilic polymer in the reagent layer, solutions of organic solvents such as alcohols, ethers, and ketones are useful. For example, ethanol, methanol, acetone, ethyl cellosolve, etc. can be used. .
また、標識抗原を含む多孔性試薬層の上に、抗体を予め
含浸、塗布等により含有した多孔性層を、例えば特開昭
61−4959号等のような方法で接着させる方法も有
用である。Furthermore, it is also useful to adhere a porous layer containing an antibody by impregnating or coating it in advance onto a porous reagent layer containing a labeled antigen using a method such as that described in JP-A No. 61-4959. .
多孔性層への含浸または塗布には公知の方法を利用でき
る。塗布には例えばディップ塗布、ドクター塗布、ホッ
パー塗布、カーテン塗布等を適宜選択して用いる。Known methods can be used for impregnating or coating the porous layer. For the coating, dip coating, doctor coating, hopper coating, curtain coating, etc. are appropriately selected and used.
本発明における多孔性層は、分析要素の最上層であって
もよいし、最上層と試薬層の間にある層でもよい。供給
される液体の量にほぼ比例した面積に液体を展開する、
いわゆる計量作用を有する液体展開層(以下、展開層と
いうことがある)であってもよいし、それ以外でもよい
。繊維質であってもよいし、非繊維質でもよい、天然繊
維がち成る布、合成または半合成繊維から成る布、不織
布、紙、酢酸セルロース等から成るメンブランフィルタ
−1!!li機物または有機物粒子の結合体等のいずれ
でもよい、Iffえば特開昭55−164356号、同
60−222769号等に記載された繊!!質層のほか
、特開昭49−53888号、特開昭58−70163
号、同61−4959号、特願昭60−256408号
、同60−279859号、同60−279860号、
同60−279861号等に記載されたような多孔性層
も好適である。The porous layer in the present invention may be the top layer of the analytical element or a layer between the top layer and the reagent layer. spreading the liquid over an area approximately proportional to the amount of liquid supplied;
It may be a liquid spreading layer having a so-called metering effect (hereinafter sometimes referred to as a spreading layer), or it may be other than that. Membrane filter made of cloth made of natural fibers, cloth made of synthetic or semi-synthetic fibers, nonwoven fabric, paper, cellulose acetate, etc. which may be fibrous or non-fibrous - 1! ! It may be a combination of organic particles or organic particles, for example, the fibers described in JP-A-55-164356 and JP-A-60-222769. ! In addition to the quality layer, JP-A-49-53888, JP-A-58-70163
No. 61-4959, Japanese Patent Application No. 60-256408, No. 60-279859, No. 60-279860,
A porous layer such as that described in Japanese Patent No. 60-279861 is also suitable.
抗原を蛍光標識するためには種々の蛍光物質を用いるこ
とができる。それらは官能成分により分類することがで
きるが、例えばアミノ基を有する蛍光物質として
1−アミノナフタレン
2−アミノナフタレン
p、p’−ジアミノスチルベン
2−アミノアクリジン
p、p’−ジアミノベンゾフェノンイミン類ビス−3−
アミンピリジニウム塩
インドール票
フェノール性蛍光物質として
7−ヒドロキシクマリン類
3.6−シヒドロキシキサンテン頚
ステロフェール類
デトラサイクリン
サリチル酸エステル項
等が挙げられる0代表的なものは、フルオレセインであ
る。Various fluorescent substances can be used to fluorescently label an antigen. They can be classified according to their functional components, and for example, fluorescent substances with amino groups include 1-aminonaphthalene 2-aminonaphthalene p, p'-diaminostilbene 2-aminoacridine p, p'-diaminobenzophenone imine bis- 3-
Examples of phenolic fluorescent substances include amine pyridinium salts, indoles, 7-hydroxycoumarins, 3,6-hydroxyxanthenes, cervical sterophels, detracycline salicylic acid esters, etc.A typical example is fluorescein.
抗原は発光物質、例えば化学発光物質で標識されてもよ
い0例えば、ルミノールで代表される2)3−ジヒドロ
−1,4−フタラジンジオン、あるいは2.4.5−)
リフェニルイミダゾール類を用いることができる。The antigen may be labeled with a luminescent substance, such as a chemiluminescent substance, e.g. 2) 3-dihydro-1,4-phthalazinedione, typified by luminol, or 2.4.5-)
Riphenylimidazoles can be used.
抗原を酵素標識する場合、種々の酵素を用いることがで
きる。充分高い酵素活性が得られること、酵素の安定性
、酵素活性への結合の影響等を考慮して、酵素が選択さ
れる。特表昭56−500901号明細嘗の第1表およ
び第2表に記載されたものから選ぶことができる。代表
的なものはグルコースオキシダーゼ(G○[))、β−
D−ガラクトシダーゼ、ペルオキシダーゼ(POD>、
アルカリ性ホスファターゼ(ALP)、α−アミラーゼ
、ルシフェラーゼ等である。When enzymatically labeling an antigen, various enzymes can be used. Enzymes are selected taking into consideration the ability to obtain sufficiently high enzyme activity, the stability of the enzyme, the influence of binding on enzyme activity, and the like. It can be selected from those listed in Tables 1 and 2 of the specification of Japanese Patent Application Publication No. 56-500901. Representative ones are glucose oxidase (G○[)), β-
D-galactosidase, peroxidase (POD>,
These include alkaline phosphatase (ALP), α-amylase, and luciferase.
抗原に標識を結合させる方法および本発明に用いること
ができる標識抗原については、石川栄治ら:「酵素免疫
測定法(第2版)J(1982年)河合忠編:「臨床検
査技術全書4免疫血清検査」(医学書院、1977年発
行)、97−102頁、B 1oehe+m、 B 1
opl+ys、Res、c oa++sun、 、74
,538(1977)、C11nica Cl+i+*
ica Acta 、83,161(1978)等の記
載が参照できる。Regarding the method of binding a label to an antigen and the labeled antigen that can be used in the present invention, please refer to Eiji Ishikawa et al.: "Enzyme immunoassay (2nd edition) J (1982), edited by Tadashi Kawai: "Clinical Testing Techniques Complete Book 4 Immunology. Serum Test” (Igakushoin, published in 1977), pp. 97-102, B 1oehe+m, B 1
opl+ys, Res, coa++sun, , 74
, 538 (1977), C11nica Cl+i+*
ica Acta, 83, 161 (1978), etc. can be referred to.
rs抗原の具体例としてフルオレセインインチオシアネ
ート結hチロキシンFITCT4゜GOD結合ヒI・免
疫グロブリン(IgG)、ALP結合IgG、PODP
!A!α−フェトプロティン等がある。Specific examples of rs antigens include fluorescein inthiocyanate tyroxine FITCT4゜GOD-binding human immunoglobulin (IgG), ALP-binding IgG, and PODP.
! A! Examples include α-fetoprotein.
本発明は公知の多種の乾式分析要素に適用することが出
来る。要素は多孔性層、試薬層のほが、支持体、展開層
、検出層、光遮蔽層、接側りろ過層、吸水層、下塗り層
その他の層を含む多重層の構成を有してもよい、かよう
な分析要素として、米国特許第3.992.158号、
同4,042,335号および特開昭55−16435
6号各明細書に開示されたものがある。The present invention can be applied to various known dry analysis elements. The element may have a multilayer configuration including a porous layer, a reagent layer, a support, a spreading layer, a detection layer, a light shielding layer, an adjacent filtration layer, a water absorption layer, a subbing layer, and other layers. A good example of such an analytical element is U.S. Pat. No. 3,992,158;
No. 4,042,335 and JP-A-55-16435
There is something disclosed in each specification of No. 6.
光透過性水不透過性支持体を用いる場合、本発明の乾式
分析要素の実用的に採りうる構成は(1)支持体上に試
薬層、その上に展開層を有するもの。When using a light-transmitting and water-impermeable support, the practical configuration of the dry analytical element of the present invention is (1) having a reagent layer on the support and a developing layer thereon.
(2)支持体上に検出層、試薬層、展開層をこの順に有
するもの。(2) A device having a detection layer, a reagent layer, and a developing layer in this order on a support.
(3)支持体上に試薬層、光反射層、展開層をこの順に
有するもの。(3) One having a reagent layer, a light reflecting layer, and a developing layer in this order on a support.
(4)支持体上に検出層、試薬層、光反射層、展開層を
この順に有するもの。(4) A support having a detection layer, a reagent layer, a light reflection layer, and a development layer in this order.
(5)支持体上に検出層、光反射層、試薬層、展開層を
この順に有するもの。(5) A support having a detection layer, a light reflection layer, a reagent layer, and a development layer in this order.
(6)支持体上に第二試薬層、光反射層、第一試薬層、
展開層をこの順に有するもの。(6) a second reagent layer, a light reflection layer, a first reagent layer on the support,
It has development layers in this order.
(7)支持体、上に検出層、第二試薬層、光反射層、第
一試薬層、展開層をこの順に有するもの。(7) A support having a detection layer, a second reagent layer, a light reflection layer, a first reagent layer, and a developing layer thereon in this order.
上記(1)ないしく5)において試薬層は異なる複数の
層から成ってもよい、支持体と試薬層または検出層との
間には吸水層を設けてもよい、上記(1)ないしく3)
と(6)において試薬層と検出層または展開層の間にろ
過層を設けてもよい。In (1) to 5) above, the reagent layer may consist of a plurality of different layers, a water absorption layer may be provided between the support and the reagent layer or detection layer, and (1) to 3 above. )
In (6), a filtration layer may be provided between the reagent layer and the detection layer or development layer.
上記(3)ないしく7)において光反射層と検出層、試
薬層または展開層との間、試薬層と検出層との間または
試薬層と展rmMIの間に、さらにろ過層を設けてもよ
い、試薬層が複数層から成る場合に、試薬層と試薬層の
間にさらにろ過層を設けてもよい。In (3) to 7) above, a filtration layer may be further provided between the light reflection layer and the detection layer, the reagent layer or the spreading layer, between the reagent layer and the detection layer, or between the reagent layer and the spreading rmMI. In the case where the reagent layer is composed of multiple layers, a filtration layer may be further provided between the reagent layers.
本発明の乾式分析要素の試薬層としては、親水性ポリマ
ーを結合剤とする実質的に均一の層のほか、例えば特開
昭58−70163号、特開昭61−4959号、特願
昭60−256408号、同60−279859号、同
60−279859号、同60−279861号等に記
載されたような多孔性層も好適である。Ni水性ポリマ
ーとして例えば、ゼラチンおよびこれらの誘導体く例え
ばフタル化ゼラチン〉、セルロース誘導体(rIAえば
ヒドロキシメチルセルロース)、アガロース、アクリル
アミド重合体、メタアクリルアミド重合体、アクリルア
ミドまたはメタアクリルアミドと各種ビニル性モノマー
との共重合体等が利用できる。As the reagent layer of the dry analytical element of the present invention, in addition to a substantially uniform layer containing a hydrophilic polymer as a binder, examples include JP-A-58-70163, JP-A-61-4959, and JP-A-Sho 60. Porous layers such as those described in No. 256408, No. 60-279859, No. 60-279859, and No. 60-279861 are also suitable. Examples of Ni aqueous polymers include gelatin and derivatives thereof such as phthalated gelatin>, cellulose derivatives (rIA such as hydroxymethylcellulose), agarose, acrylamide polymers, methacrylamide polymers, acrylamide or methacrylamide in combination with various vinyl monomers, etc. Polymers etc. can be used.
試薬層には必要に応じ酵素に対する基質、酸化剤、カプ
ラー、H衝剤等を含有させることができる。試薬層に酵
素標識抗原を含む場合には、当該酵素に対する基質が必
要とされる。The reagent layer can contain a substrate for the enzyme, an oxidizing agent, a coupler, an H buffering agent, etc., if necessary. When the reagent layer contains an enzyme-labeled antigen, a substrate for the enzyme is required.
本発明の分析要素の試薬層に含有させることができる緩
衝剤の例としては、炭酸塩、ホウ酸塩、燐酸塩やBio
cbemisLry誌 第5巻 第2号、467ページ
より477ページ(1966年)に記載されているグツ
ド(Good )の!8剤などを挙げることができる。Examples of buffers that can be contained in the reagent layer of the analytical element of the present invention include carbonates, borates, phosphates, and
Good's as described in cbemisLry magazine Vol. 5 No. 2, pages 467 to 477 (1966)! 8 agents can be mentioned.
これらの緩衝剤はr蛋白質・酵素の基礎実験法J(堀尾
武−ほか著、南江堂、1981年)、前記Bioche
+*1sLry誌第5巻等の文献を参考にして選択する
ことができる。These buffers are described in Basic Experimental Methods for Proteins and Enzymes J (Takeshi Horio et al., Nankodo, 1981), the above-mentioned Bioche
The selection can be made by referring to literature such as +*1sLry Magazine Volume 5.
多孔性層を展開層として利用する場合、液体計量作用を
有する層であることが好ましい、液体計量作用とは、そ
の表面に点着供給された?lI体試料を、その中に含有
している成分を実質的に偏在させることなく、面の方向
に単位面積当りほぼ一定量の割なで広げる作用である。When a porous layer is used as a spreading layer, it is preferably a layer that has a liquid metering effect. This is an effect of spreading the II sample in a substantially constant amount per unit area in the plane direction without substantially unevenly distributing the components contained therein.
展開層その他の多孔性層を構成する材料としては、1紙
、不織布、織物生地〈例えば平織生地)、編物生地(例
えば、トリコット#i)、ガラス繊維r紙等を用いるこ
とができる。展開層としては、これらのうち織物、編物
等が好ましい、織物等は特開昭57−66359号に記
載されたようなグロー放;処理をしてもよい。展開層に
は、RR凹面積展開速度等を調節するため、1キ開昭6
0−222770号、特願昭61−122875号、6
1−122876号、6 ]−−143754号に記載
したような親水性高分子あるいは界面活性剤を含有して
もよい。As materials constituting the spreading layer and other porous layers, paper, nonwoven fabric, woven fabric (for example, plain weave fabric), knitted fabric (for example, tricot #i), glass fiber r paper, etc. can be used. Among these, woven fabrics, knitted fabrics, etc. are preferable as the developing layer, and woven fabrics may be treated with glow release as described in JP-A No. 57-66359. In order to adjust the RR concave area development speed etc. in the development layer, 1ki Kaisho 6
No. 0-222770, Patent Application No. 122875-1987, 6
1-122876, 6]--143754 may be contained.
多孔性層を接着し積層するための接着層を、試薬層、光
道へい層、81過層、吸水層、検出層等の層の上に設け
てもよい、接着層は水で15j潤したときに多孔性層を
接着することができるような親水性ポリマー、例えばゼ
ラチン、ゼラチン誘導体、ポリアクリルアミド、澱粉等
からなることが好ましい。An adhesive layer for adhering and laminating the porous layer may be provided on layers such as a reagent layer, a light guide layer, an 81 superlayer, a water absorption layer, a detection layer, etc. The adhesive layer is moistened with water for 15 minutes. It is preferably composed of a hydrophilic polymer, such as gelatin, gelatin derivatives, polyacrylamide, starch, etc., to which the porous layer can sometimes be adhered.
光遮蔽層は、検出層、試薬層等に生じた検出可能な変化
(色変化、発色等)を光透過性を有する支持体側から反
射測光する際に、展開層に点着供給された被検液の色、
特に試料が全血である場会のヘモグロビンの赤色等を遮
蔽するとともに光反射層または背景層として機能する。The light-shielding layer is used to measure the detectable changes (color change, color development, etc.) that occur in the detection layer, reagent layer, etc. from the light-transmitting support side. liquid color,
In particular, when the sample is whole blood, it blocks the red color of hemoglobin and functions as a light-reflecting layer or background layer.
光遮蔽層は、皮膜形成能を有する親水性ポリマーをバイ
ンダーとして、酸化チタン、硫酸バリウム等の光反射性
微粒子が分散された水浸透性の層であることが好ましい
。バインダーとしてはゼラチン、ゼラチン誘導体、ポリ
アクリルアミド等が好ましい0分析要素には、光遮蔽層
を設ける代わりに、またはそれと同時に、展rM層、試
薬層、検出層等に酸化チタン等の光反射粒子を含有させ
てもよい。The light shielding layer is preferably a water-permeable layer in which light-reflecting fine particles such as titanium oxide and barium sulfate are dispersed using a hydrophilic polymer having film-forming ability as a binder. As the binder, gelatin, gelatin derivatives, polyacrylamide, etc. are preferable. For analytical elements, instead of providing a light-shielding layer, or at the same time, light-reflecting particles such as titanium oxide may be applied to the spreading layer, reagent layer, detection layer, etc. It may be included.
C実施例] (74測定用多層免疫一体型要素)〔1〕
フルオレセイン標識チロキシンの合成特開昭59−17
0768に記載されている手法により、フルオレセイン
標識チロキシン(以下FITC−T、)を合成した。Example C] (Multilayer immune-integrated element for 74 measurements) [1]
Synthesis of fluorescein-labeled thyroxine JP-A-59-17
Fluorescein-labeled thyroxine (hereinafter referred to as FITC-T) was synthesized by the method described in 0768.
〔2〕抗チロキシン抗血清の分散液の調製下記の処方の
液をホモジナイザーで1時間分散し、抗チロキシン抗血
清分散液を調製した。[2] Preparation of anti-thyroxine antiserum dispersion A liquid with the following formulation was dispersed for 1 hour using a homogenizer to prepare an anti-thyroxine antiserum dispersion.
抗チロキシン抗血清 1i+1(凍結乾燥
粉末として)
ノニルフェノキシ
ポリエトキシエタノール(*) 0.2Hアセトン
100g* rl= 15
C3) 多Rシー トノlil:vA
ゼラチン下塗りされている厚さ180μ屑のポリエチレ
ンテレフタレート無色透明平滑フィルム上に下記の組成
(a)の水溶液を乾燥後の厚さが2μlになるように塗
布し、02燥した(試薬層)(a) ゼラチン
10g水 190g
ホルマリン 0.2FI
FITC−7,120μg
さらに上記試薬層の上に乾燥後の厚さが約2μlになる
ようにゼラチンを塗布し、タイミング層とした。Anti-thyroxine antiserum 1i+1 (as lyophilized powder) Nonylphenoxypolyethoxyethanol (*) 0.2H acetone
100g* rl = 15 C3) Multi-R sheet Tonolil:vA Aqueous solution of the following composition (a) is dried on a 180μ thick colorless transparent smooth film of polyethylene terephthalate coated with gelatin so that the thickness after drying becomes 2μl. (Reagent layer) (a) Gelatin
10g Water 190g Formalin 0.2FI FITC-7, 120μg Furthermore, gelatin was coated on the above reagent layer so that the thickness after drying was about 2μl to form a timing layer.
上記タイミング層を約30g/z”の水で湿らせた後、
ポリエチレンテレフタレート紡績紙(36ゲージ、50
D)からなるトリコット編物を圧着し、乾燥されて展開
層とした。After wetting the timing layer with about 30 g/z” of water,
Polyethylene terephthalate spun paper (36 gauge, 50
The tricot knitted fabric consisting of D) was pressed and dried to form a spread layer.
上記展開層に下記の組成(L+)の塗布液を120 c
c/x”の割合で塗布、乾燥し、TJI定m一体型多層
分析要素(1)を作製した。Apply 120 c of a coating solution having the following composition (L+) to the above development layer.
It was coated at a ratio of "c/x" and dried to produce a TJI constant m integrated multilayer analytical element (1).
<b>抗チロキシン抗血清分散液 5Nポリビニル
ピロリドン 25g
ノニルフェノキシ
ポリエトキシエタノール(*) 0.21FIメチル
アルコール 500d
*n=15
また、塗布液(b )の組成を下記(c)に変えた以外
は全く同様にしてT、i走用一体型多層分析要素(2)
を作製した。<b> Anti-thyroxine antiserum dispersion 5N polyvinylpyrrolidone 25g Nonylphenoxypolyethoxyethanol (*) 0.21FI methyl alcohol 500d *n=15 Also, except that the composition of the coating liquid (b) was changed to the following (c) In exactly the same way, integrated multilayer analysis element for T and i running (2)
was created.
(C)抗チロキシン抗血清分散液 5z/ポリビニ
ルとロリドン 25y
ノニルフエノキシ
ポリエトキシエタノール(*) 0.2xfl水
500zf〔4〕チロキシ
ン(T、)り)測定
血清を活性炭で処理してT4フリー血清を得、これに既
知量のチロキシンを添加して得た種々の濃度のカリブレ
ーション用チロキシン(T、)含有血清10μ!に
0.3Mグリ シン′−N a CR−N a OH1
ii衝ン1 5μmとブロッカ−試薬(ドデシルナフタ
レスルホン酸ナトリウム)0.1M水溶液5μlを加え
た混合物20μlを各多層分析要素の展開層に滴下した
。(C) Anti-thyroxine antiserum dispersion 5z/Polyvinyl and Lolidone 25y Nonylphenoxypolyethoxyethanol (*) 0.2xfl water
500zf [4] Thyroxine (T,) measurement Serum was treated with activated charcoal to obtain T4-free serum, and a known amount of thyroxine was added to this to obtain thyroxine (T,) at various concentrations for calibration. Serum 10μ! to 0.3M glycine'-N a CR-N a OH1
20 μl of a mixture of a 15 μm bomb and 5 μl of a 0.1 M aqueous solution of a blocker reagent (sodium dodecylnaphthalesulfonate) was dropped onto the developing layer of each multilayer analytical element.
25℃で30分放置した後ポリエチレンテレフタレート
フィルム側から反射蛍光を測定した0反射蛍光の測定に
は日立製作所製蛍光光度Zt 650−10 (S)を
用い、励起波長495nm、蛍光波長525nmで測定
を実施した。After standing at 25°C for 30 minutes, reflected fluorescence was measured from the polyethylene terephthalate film side. 0 Reflected fluorescence was measured using Hitachi Fluorescence Zt 650-10 (S) at an excitation wavelength of 495 nm and a fluorescence wavelength of 525 nm. carried out.
得られた検量線は第1図に示す通りである。The obtained calibration curve is as shown in FIG.
第1図より分析要素(1)は分析要素(2)に較べて著
しく性能が良いことがわかる。It can be seen from FIG. 1 that analytical element (1) has significantly better performance than analytical element (2).
第1図は実施例1の免疫分析要素の蛍光測定により得ら
れたT、の検l線である。
出願人 富士写真フィルム株式会社
第1図
T4(μg/jf)
手続補正書
昭和63年3月25日FIG. 1 is a calibration line of T obtained by fluorescence measurement of the immunoassay element of Example 1. Applicant Fuji Photo Film Co., Ltd. Figure 1 T4 (μg/jf) Procedural amendment March 25, 1988
Claims (1)
、該層の一つは多孔性層、他の一つは試薬層であり、試
薬層は多孔性層の液体を受容する面と反対側に位置して
おり、抗原/抗体反応に関与する成分を水浸透性層に含
む乾式免疫分析要素であって、 上記抗原/抗体反応に関与する成分の一つは標識抗原、
他の一つは非標識および標識抗原に対する抗体であり、
前記抗体の実質的に全部が多孔性層に含まれ、前記標識
抗原の実質的に全部が試薬層に含まれることを特徴とす
る乾式免疫分析要素。 2)特許請求の範囲1)において多孔性層が液体展開層
であることを特徴とする分析要素。 3)一体化された少なくとも2つの水浸透性層から成り
、該層の一つは多孔性層、他の一つは試薬層であり、試
薬層は多孔性層の液体を受容する面と反対側に位置して
おり、抗原/抗体反応に関与する成分を水浸透性層に含
む乾式免疫分析要素の製造方法であって、 前記標識抗原を含む試薬層の上に多孔性層を設けた後、
前記抗体を含み試薬層中の標識抗原を溶解または可溶化
しない組成物を多孔性層に塗布または含浸することを特
徴とする方法。 4)特許請求の範囲3)において多孔性層が液体展開層
であることが特徴である方法。 5)一体化された少なくとも2つの水浸透性層から成り
、該層の一つは多孔性層、他の一つは試薬層であり、試
薬層は多孔性層の液体を受容する面と反対側に位置して
おり、抗原/抗体反応に関与する成分を水浸透性層に含
む乾式免疫分析要素の製造方法であって、 前記標識抗原を含む試薬層の上に、前記抗体を含む組成
物を予め塗布または含浸した多孔性層を設けることを特
徴とする方法。 6)特許請求の範囲5)において多孔性層が液体展開層
であることが特徴である方法。[Scope of Claims] 1) Consisting of at least two water-permeable layers integrated, one of which is a porous layer and the other a reagent layer, the reagent layer being a liquid permeable layer in the porous layer. The dry immunoassay element is located on the opposite side to the surface that receives the antigen and contains components involved in the antigen/antibody reaction in a water-permeable layer, and one of the components involved in the antigen/antibody reaction is a label. antigen,
The other is antibodies against unlabeled and labeled antigens,
A dry immunoassay element, wherein substantially all of the antibody is contained in a porous layer, and substantially all of the labeled antigen is contained in a reagent layer. 2) An analytical element according to claim 1, characterized in that the porous layer is a liquid spreading layer. 3) Consists of at least two integrated water-permeable layers, one of which is a porous layer and the other a reagent layer, the reagent layer being opposite to the liquid-receiving side of the porous layer. A method for producing a dry immunoassay element in which a water-permeable layer contains a component that is located on the side and is involved in an antigen/antibody reaction, the method comprising: providing a porous layer on the reagent layer containing the labeled antigen; ,
A method comprising applying or impregnating a porous layer with a composition that includes the antibody and does not dissolve or solubilize the labeled antigen in the reagent layer. 4) The method according to claim 3), characterized in that the porous layer is a liquid spreading layer. 5) Consists of at least two integrated water-permeable layers, one of which is a porous layer and the other a reagent layer, the reagent layer being opposite to the liquid-receiving side of the porous layer. A method for producing a dry immunoassay element comprising a component involved in an antigen/antibody reaction in a water-permeable layer located on the side, the composition comprising the antibody being placed on the reagent layer comprising the labeled antigen. A method characterized by providing a porous layer pre-coated with or impregnated with. 6) The method according to claim 5), wherein the porous layer is a liquid spreading layer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5463587A JPS63221246A (en) | 1987-03-10 | 1987-03-10 | Dry type immunoassary element |
DE19883807756 DE3807756A1 (en) | 1987-03-10 | 1988-03-09 | Dry analytical element for an immunoassay |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5463587A JPS63221246A (en) | 1987-03-10 | 1987-03-10 | Dry type immunoassary element |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63221246A true JPS63221246A (en) | 1988-09-14 |
Family
ID=12976224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5463587A Pending JPS63221246A (en) | 1987-03-10 | 1987-03-10 | Dry type immunoassary element |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS63221246A (en) |
DE (1) | DE3807756A1 (en) |
-
1987
- 1987-03-10 JP JP5463587A patent/JPS63221246A/en active Pending
-
1988
- 1988-03-09 DE DE19883807756 patent/DE3807756A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE3807756A1 (en) | 1988-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5160486A (en) | Test carrier utilizing reaction of two bioaffine binding partners | |
US5110550A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
EP0051183B2 (en) | Multilayer analysis element | |
US4587102A (en) | Multi-layer analysis element utilizing specific binding reaction | |
US4340564A (en) | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate | |
JPH0726959B2 (en) | Whole blood analysis element | |
JP2576910B2 (en) | Immunoassay element and immunoassay method | |
JPH0750114B2 (en) | Analysis method using immunoassay instrument | |
CA2019980C (en) | Analytical assay method | |
JPH0726960B2 (en) | Dry whole blood analysis element | |
US5266460A (en) | Method of preparing immunological analytical element | |
US5338513A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
EP0114403B1 (en) | Multilayer analytical element | |
JP4437211B2 (en) | Measuring method using immunochromatography and sample analysis tool used therefor | |
JPH01227964A (en) | Production of immunological analysis element | |
JP2001228151A (en) | Immunological chromatographic device | |
JPS63221246A (en) | Dry type immunoassary element | |
JP2576913B2 (en) | Immunoassay element and immunoassay method | |
JPH01237455A (en) | Dry immunity analyzing element | |
JPS63228068A (en) | Production of immunological analysis element | |
JPH09184840A (en) | Testing jig for immunochromatography | |
JPH01229968A (en) | Dry type immunity analysis element | |
USH1664H (en) | Analytical element for immunoassay and method for its preparation | |
JPH0255952A (en) | Dry chemical reagent release product, manufacture thereof and analysis method and test kit using the same | |
JP2616805B2 (en) | Dry immunoassay element |